LJ

Lena Jayant Gajjar

Director Director DIN 00699478
DIN 00699478 First appointment Aug 1951 Primary industry Education
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 1951
Shareholding value β€’β€’β€’β€’ Premium profile

About Lena Jayant Gajjar

Data last updated:

Lena Jayant Gajjar was a Director at Vanita Vishram (2001–2019) and Director at Pathological Laboratories Private Limited (from 1951). The companies operate in Education.

DIN 00699478
Primary Designation Director
Industry Education
First Appointment 04 Aug 1951
Oldest Company Age 75 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vanita Vishram U80300MH1928GAP001375
Director26 May 20011928₹59.40 Cr (FY 2024)Active
Director04 Aug 19511951Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pathological Laboratories Private Limited
Vanita Vishram
Premium access

Shareholding and investment profile for Lena Jayant Gajjar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lena Jayant Gajjar

Lena Jayant Gajjar was first appointed on 04 Aug 1951 as Director at Pathological Laboratories Private Limited. The most recent appointment on record is 26 May 2001 at Vanita Vishram.

Lena Jayant Gajjar held 2 earlier board appointments: Vanita Vishram (Director, 26 May 2001 to 24 Apr 2019); Pathological Laboratories Private Limited (Director, from 04 Aug 1951).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available